Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data

NCT06435091 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT06435091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data
Lead sponsor
Helse Stavanger HF
Phase
Observational
Overall status
Active, not recruiting
Start date
December 15, 2023
Completion date
June 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer related fatigue